Business
Bionano Genomics Announces Participation at the American Association for Cancer Research Annual Meeting Spotlighting Optical Genome Mapping Applications and Enhanced NxClinical Capabilities for Cancer Research
Bionano will exhibit all of its solutions relevant to cancer research: OGM systems, NxClinical software and expert laboratory servicesExhibitor Theater
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"Bionano will exhibit all of its solutions relevant to cancer research: OGM systems, NxClinical software and expert laboratory servicesExhibitor Theater presentation will share the latest OGM research on comprehensive genomic structural variation and homologous recombination deficiency (HRD) analysis from tumor biopsiesThree scientific poster presentations will illustrate the application of Bionano’s OGM in hematological disease, cell line characterization and angiosarcomaBionano will introduce NxClinical version 6.2, which will include powerful capabilities for analysis of homologous recombination deficiency (HRD) SAN DIEGO, April 05, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced that it is participating in-person at the American Association for Cancer Research (AACR) Annual Meeting. AACR conference sessions will take place April 8-13, 2022, in New Orleans, Louisiana with an option for virtual attendance. Bionano will exhibit its complete portfolio of products and services relevant to the cancer research community including OGM solutions, NxClinical software and laboratory services. Multiple attendees from both the scientific and commercial teams will participate in the conference. As part of a featured spotlight talk, two cancer genomics experts will share their latest research in comprehensive genomic structural variation and HRD analysis of tumor biopsies, which included OGM and NGS. Dr. Ravindra Kolhe, from the Medical College of Georgia/Augusta University, and Dr. Miriam Bornhorst, from Children’s National Hospital, will present in the Exhibitor Theater on Tuesday, April 12, 2022. In addition, three posters featuring results from OGM applications will be presented at the conference. The full content of the posters will be made available on the Bionano Genomics website once presented at the conference. PosterTitleAuthorsPresented5783Novel genomic structural variations in angiosarcomasThuy L. Phung, Joyce Lee, Wa DuApril 8, 202212:00 - 1:00 PM2931Optical genome mapping workflow for identification and annotation of variants in hematological malignanciesJennifer Hauenstein, Andy Pang, Alka Chaubey, Alex Hastie...